Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Oehme

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|September 26, 2025
New cell lines expanding the diversity of Ewing sarcoma modelsMaximilian Kerkhoff, Christiane Schaefer, Wilhelm G Dirks, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Neuro-Oncology Advances|April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastomaSonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
Journal of Medicinal Chemistry|December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma ActivityTino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Chemmedchem|April 30, 2020
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 InhibitorsMichael Morgen, Raphael R Steimbach, Magalie Géraldy, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
European Journal of Medicinal Chemistry|March 20, 2022
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cellsPatrik Zeyen, Yanira Zeyn, Daniel Herp, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|September 26, 2025
New cell lines expanding the diversity of Ewing sarcoma modelsMaximilian Kerkhoff, Christiane Schaefer, Wilhelm G Dirks, et al.
Clinical Pharmacology and Therapeutics|July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical StudiesNora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Neuro-Oncology Advances|April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastomaSonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
Journal of Medicinal Chemistry|December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma ActivityTino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Chemmedchem|April 30, 2020
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 InhibitorsMichael Morgen, Raphael R Steimbach, Magalie Géraldy, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
European Journal of Medicinal Chemistry|March 20, 2022
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cellsPatrik Zeyen, Yanira Zeyn, Daniel Herp, et al.
Pageof 9